These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1173 related items for PubMed ID: 7799346

  • 1. Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus.
    Cohen MR, Crosby D.
    J Rheumatol; 1994 Sep; 21(9):1665-9. PubMed ID: 7799346
    [Abstract] [Full Text] [Related]

  • 2. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
    Vera-Recabarren MA, García-Carrasco M, Ramos-Casals M, Herrero C.
    Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
    [Abstract] [Full Text] [Related]

  • 3. IL-17 in cutaneous lupus erythematosus.
    Tanasescu C, Balanescu E, Balanescu P, Olteanu R, Badea C, Grancea C, Vagu C, Bleotu C, Ardeleanu C, Georgescu A.
    Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
    [Abstract] [Full Text] [Related]

  • 4. Classification of lupus erythematosus based upon Japanese patients.
    Tsuchida T.
    Autoimmun Rev; 2009 May; 8(6):453-5. PubMed ID: 19162249
    [Abstract] [Full Text] [Related]

  • 5. Drug-induced lupus: an update on its dermatologic aspects.
    Marzano AV, Vezzoli P, Crosti C.
    Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
    [Abstract] [Full Text] [Related]

  • 6. Subacute cutaneous lupus erythematosus presenting as poikiloderma.
    Hughes R, Loftus B, Kirby B.
    Clin Exp Dermatol; 2009 Dec; 34(8):e859-61. PubMed ID: 20055848
    [Abstract] [Full Text] [Related]

  • 7. A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus.
    Popovic K, Nyberg F, Wahren-Herlenius M, Nyberg F.
    Arthritis Rheum; 2007 Jan; 56(1):255-64. PubMed ID: 17195229
    [Abstract] [Full Text] [Related]

  • 8. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).
    Tiao J, Feng R, Carr K, Okawa J, Werth VP.
    J Am Acad Dermatol; 2016 May; 74(5):862-9. PubMed ID: 26897388
    [Abstract] [Full Text] [Related]

  • 9. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A, da Silva LM, Oliveira FR, Roselino AM, Louzada-Junior P.
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [Abstract] [Full Text] [Related]

  • 10. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications.
    Chlebus E, Wolska H, Blaszczyk M, Jablonska S.
    J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021
    [Abstract] [Full Text] [Related]

  • 11. [Anticardiolipin antibodies in cutaneous lupus erythematosus. Incidence and importance as a marker of vascular symptoms].
    Tebbe B, Orfanos CE.
    Hautarzt; 1992 Mar; 43(3):130-3. PubMed ID: 1577600
    [Abstract] [Full Text] [Related]

  • 12. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
    Lampropoulos CE, Sangle S, Harrison P, Hughes GR, D'Cruz DP.
    Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
    [Abstract] [Full Text] [Related]

  • 13. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
    Järvinen TM, Kanninen P, Jeskanen L, Koskenmies S, Panelius J, Hasan T, Ranki A, Saarialho-Kere U.
    Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
    [Abstract] [Full Text] [Related]

  • 14. Drug-induced lupus erythematosus.
    Vedove CD, Del Giglio M, Schena D, Girolomoni G.
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [Abstract] [Full Text] [Related]

  • 15. Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart.
    Marzano AV, Lazzari R, Polloni I, Crosti C, Fabbri P, Cugno M.
    Br J Dermatol; 2011 Aug; 165(2):335-41. PubMed ID: 21564069
    [Abstract] [Full Text] [Related]

  • 16. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA, Mbuagbaw J, Burge SM.
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [Abstract] [Full Text] [Related]

  • 17. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset.
    Sontheimer RD, Thomas JR, Gilliam JN.
    Arch Dermatol; 1979 Dec; 115(12):1409-15. PubMed ID: 533284
    [Abstract] [Full Text] [Related]

  • 18. [Subacute cutaneous lupus erythematosus].
    Jore S, Gran JT.
    Tidsskr Nor Laegeforen; 1997 May 30; 117(14):2040-2. PubMed ID: 9235684
    [Abstract] [Full Text] [Related]

  • 19. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients.
    Chanprapaph K, Tubtieng I, Pratumchat N, Thadanipon K, Rattanakaemakorn P, Suchonwanit P.
    Lupus; 2021 Apr 30; 30(5):785-794. PubMed ID: 33554715
    [Abstract] [Full Text] [Related]

  • 20. Keratinocyte and lymphocyte apoptosis: relation to disease outcome in systemic lupus erythematosus patients with and without cutaneous manifestations.
    Salem SA, Farouk HM, Mostafa AA, Hassan IM, Osman WM, Al-Shamy HA, Assaf NY.
    Eur J Dermatol; 2010 Apr 30; 20(1):35-41. PubMed ID: 19919906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.